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Abstract
Background: Rapeseed oil is the principal dietary source of monounsaturated and n-3 polyunsaturated fatty acids
in the Northern Europe. However, the effect of rapeseed oil on the markers of subclinical atherosclerosis is not
known. The purpose of this study was to compare the effects of dietary intake of cold-pressed turnip rapeseed oil
(CPTRO) and butter on serum lipids, oxidized LDL and arterial elasticity in men with metabolic syndrome.
Methods: Thirty-seven men with metabolic syndrome completed an open and balanced crossover study.
Treatment periods lasted for 6 to 8 weeks and they were separated from each other with an eight-week washout
period. Subjects maintained their normal dietary habits and physical activity without major variations. The daily fat
adjunct consisted either of 37.5 grams of butter or 35 mL of Virgino
R CPTRO. Participants were asked to spread
butter on bread on the butter period and to drink CPTRO on the oil period. The fat adjunct was used as such
without heating or frying.
Results: Compared to butter, administration of CPTRO was followed by a reduction of total cholesterol by 8% (p <
0.001) and LDL cholesterol by 11% (p < 0.001). The level of oxidized LDL was 16% lower after oil period (p =
0.024). Minimal differences in arterial elasticity were not statistically significant.
Conclusion: Cold-pressed turnip rapeseed oil had favourable effects on circulating LDL cholesterol and oxidized
LDL, which may be important in the management of patients at high cardiovascular risk.
Trial registration: ClinicalTrial.gov NCT01119690.
Background
Metabolic syndrome (MetS) is an international health
problem. Risk factors included in the MetS are impaired
glucose tolerance, elevated triglyceride levels, decreased
HDL cholesterol concentration, elevated blood pressure
and central obesity [1]. The risk of developing coronary
heart disease is six to eight times greater and mortality
in coronary heart disease two to three times greater
among patients with MetS than among their healthy
controls [2-5]. Furthermore, patients with MetS are at
high risk to develop type 2 diabetes and myocardial
infarction [4,5].
Atherosclerosis begins with an accumulation of lipo-
proteins, particularly low-density lipoprotein (LDL) into
the intimae of arteries. In the arterial wall, LDL particles
undergo oxidative modification which is suggested to
play an important role in the atherosclerotic process [6].
Circulating oxidized LDL (oxLDL) seems to express the
level of oxidative stress and associate with the risk fac-
tors of MetS [7]. Oxidized LDL has also been found to
correlate with the extent of coronary heart disease and
to be an independent predictor of an atherosclerotic pla-
que occurrence [8-10].
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lium of the arterial wall [6]. Altered endothelial struc-
ture impairs the elasticity of the arteries already at an
early stage of atherosclerosis [11]. Impaired elasticity of
arteries may also result from factors affecting the elastic
properties of the arterial wall, not only the endothelium.
For example aging and hypertension may contribute to
an overproduction of collagen and breaks in elastin
fibers. Aortic stiffness has been reported to predict
future coronary events and cardiovascular death in pre-
vious studies [12]. Thus, increased level of oxLDL and
arterial stiffness might be used as early indicators of car-
diovascular disease.
Despite of its’ high total fat content, Mediterranean
type diet rich in monounsaturated fatty acids (MUFA),
decreases cardiovascular morbidity and mortality
[13,14]. MUFA diminishes susceptibility of LDL to oxi-
dation, which may contribute to this benefit [15-17].
The protective effect of n-3 polyunsaturated fatty acids
(PUFA) from marine sources has been studied widely.
However, the role of the plant derived n-3 PUFA, a
principal dietary n-3 PUFA in the western diet, is less
clear [18]. Rapeseed oil consists of high amounts of
MUFA, a composition similar to that of olive oil. Rape-
seed oil is also the main dietary source of plant-derived
n-3 PUFA in the Northern Europe. However, the effect
of rapeseed oil on the markers of subclinical athero-
sclerosis is not known.
Subjects with metabolic syndrome seem to have
increased oxLDL levels and impaired arterial elasticity
[19]. Manipulation of the fat quality in diet, to achieve
alterations in plasma lipoproteins and arterial function,
is an intriguing strategy in the prevention of athero-
sclerotic cardiovascular diseases. The aim of our study
was to assess whether a dietary intake of cold-pressed
turnip rapeseed oil (CPTRO) has beneficial effects on
serum lipids, oxidized LDL and arterial elasticity com-
pared to an intake of butter among men with metabolic
syndrome.
Methods
Subjects
The present study is a part of Hämeenlinna Metabolic
Syndrome research program HMS. It is a regional entity
investigating atherosclerotic risk factors in men with
MetS, who were referred fromp r i v a t ea n dp u b l i cc o n -
sultations in primary and secondary health care. The
inclusion criteria were male sex, age 30 to 65 years and
a fulfilment of the criteria of MetS according to the
National Cholesterol Education Program (NCEP) Adult
Treatment Panel [1]. NCEP defines MetS as the pre-
sence of at least three of the following five criteria:
1) waist circumference > 102 cm, 2) serum triglycerides
≥ 1.7 mmol/L, 3) HDL cholesterol < 1.03 mmol/L,
4) blood pressure ≥ 130/85 mmHg and 5) fasting plasma
glucose ≥ 6.1 mmol/L or diabetes.
43 study subjects, already recruited into HMS, partici-
pated in this dietary intervention study. Subjects were
individually interviewed on their medical history, dietary
habits, smoking and alcohol consumption. Physical
examination consisted of height, weight, waist circum-
ference and blood pressure measurements. Body mass
index (BMI) was calculated as weight (kg)/height² (m²).
Blood pressure was measured four times after at least
ten minutes of rest in a semi-sitting position. The indi-
vidual blood pressure was taken as a mean of these
values. The weight and blood pressure measurements
were repeated at the end of both study periods.
Research personnel performing the laboratory and arter-
ial elasticity measurements were blinded about the diet
periods.
The Ethics Committee of the Kanta-Häme Hospital
District approved the study protocol and the study fol-
lowed the ethical principles outlined in the Declaration
of Helsinki. Each study subject gave a written informed
consent.
Design and Diets
Subjects’ usual diet was supplemented with CPTRO and
butter in an open, balanced and randomized crossover
design. The study consisted of two study periods (oil
and butter) lasting from 6 to 8 weeks, and they were
separated from each other by an 8-week washout period
(Figure 1). To avoid the effect of seasonal variation on
the results, the first study period occurred from October
to December and the second period from January to
March.
At the beginning of each fat supplementation period
the participants were given both verbal and written
detailed instructions to be followed. Butter with a maxi-
mal water content of 16% and cold-pressed turnip rape-
seed oil (0.92 g/ml) were provided free of charge. The
daily fat adjunct consisted either of 37.5 grams of butter
MetS subjects
n = 37
CPTRO 
n = 20
Butter
n = 17
CPTRO 
n = 17
Butter
n = 20
Wash-out
6-8 weeks 6-8 weeks 8 weeks
Figure 1 Design of the open, randomized cross-over study.S i x
of 43 subjects withdrew during the study because they were
unable to comply with the dietary regimens.
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period and 35 mL of Virgino
R CPTRO (Kankaisten Öljy-
kasvit Ltd) on the oil period, which comprised approxi-
mately 11-12% of daily energy intake. We recommended
participants to use the fat adjunct as such, without heat-
ing or frying. To keep the diets as stable as possible,
participants were asked to spread the butter supplement
on bread during the butter period and to drink the oil
supplement as well as to eat their bread without spread
during the oil period. Besides these instructions subjects
were asked to maintain their normal dietary habits and
physical activity without major variations. Heating or
frying of other fat included in the subjects’ every-day
diet was not forbidden. To ensure that subjects’ every-
day diet and physical activity remained similar during
both periods, they were asked to fill in a structured
questionnaire on their diet as well as on the amount,
intensity and type of physical exercise during the study.
Analysis of Fatty Acids and Phenolic Compounds
The fatty acid compositions of cold-pressed turnip rape-
seed oil and butter were analysed at MTT Agrifood
Research Finland (Jokioinen, Finland). Fatty acids were
analysed as their methyl esters. The analysis was carried
out using a Hewlett Packard 5890 capillary gas chroma-
t o g r a p he q u i p p e dw i t haD B - 2 3c o l u m nc o a t e dw i t ha
cyanopropyl-stationary phase (60 m * 0.25 mm id, film
thickness 0.25 μm) and a mass selective detector.
A mixture of standard fatty acids (C4:0 - C24:1) pur-
chased from Nu-Check-Prep Inc. (Minnesota, USA) was
used as the standard to identify the peaks.
To analyze the amount of phenolic compounds, sam-
ple of CPTRO was dissolved into hexane and extracted
with 80% methanol according to a modified method of
Vuorela et al [20]. Phenolic compounds were identified
and quantified by high performance liquid chromatogra-
phy with diode array detection using analytical condi-
tions similar to those used for the determination of
alkylresorcinols [21]. Vinylsyringol (2,6-dimethoxy-4-
vinylpheol) was quantified as syringic acid.
The fatty acid compositions of the dietary fat supple-
ments i.e. Virgino
R cold-pressed turnip rapeseed oil and
butter are shown in Table 1. Butter consisted mainly of
saturated fatty acids (61.7%). Oleic acid was the main
unsaturated fatty acid found in butter. CPTRO consisted
mainly of unsaturated fatty acids (95.6%), over half of
which were monounsaturated ones. The major fatty
acids in oil were oleic acid, linoleic acid and alfa-
linolenic acid. CPTRO contained also a small amount of
phenolic compounds. Total amount of sinapine and
sinapic acid was 0.94 μm o l / 1 0 0ga n do fv i n y l s y r i n g o l
0.89 μmol/100 g. Also some smaller peaks of unknown
phenolic compounds were seen in the high performance
liquid chromatograms.
Blood Sampling and Biochemical Analysis
At the end of both dietary periods, blood samples were
collected into 10 mL EDTA tubes, 5 mL lithium-heparin
gel tubes and 2 mL natrium-fluoride tubes after a
12-hour overnight fast and at least ten minutes of rest.
Levels of HDL, LDL and total cholesterol and triglycer-
ides as well as glucose and HbA1C were analyzed by
Cobas Integra procedure (Roche). HbA1C was assessed
in % and conversed to mmol/mol [22]. The laboratory
practices strict internal quality control with daily and
monthly control samples performed by a national exter-
nal quality assurance program (Labquality Oy).
Determination of Oxidized LDL
Plasma levels of oxidized LDL were determined as
duplicates after both diet intervention periods. Determi-
nations were made according to a validated monoclonal
antibody 4E6-based capture ELISA (Mercodia AB,
Uppsala, Sweden) [7,9]. The monoclonal antibody mAb-
4E6 is the same as in the assays previously described by
Holvoet et al [8,10]. Samples were diluted with sample
buffer in two steps to gain a final dilution 1/6561. 25 μl
of each calibrator, control and diluted sample were
pipetted into wells containing mouse monoclonal anti-
oxidized LDL. 100 μl assay buffer was added into each
well. Samples were washed 6 times with automatic
Table 1 Distribution of fatty acids in cold-pressed
Virgino
R turnip rapeseed oil (CPTRO) and butter used in
the study
Fatty acids Distribution %
CPTRO Butter
10:0 capric acid 0 1.6
12:0 lauric acid 0 2.7
14:0 myristic acid 0 11.0
14:1 (ω-5) myristoleic acid 0 0.9
15:0 pentadecanoic acid 0 0.9
16:0 palmitic acid 2.9 30.0
16:1 (ω-7) palmitoleicacid 0.1 1.5
18:0 stearic acid 1.3 14.6
18:1 (ω-7) vaccenic acid 2.9 0.9
18:1 (ω-9) oleic acid 56.7 30.4
18:2 (ω-6) linoleic acid 21.9 2.0
18:3 (ω-3) alpha-linolenic acid 13.1 0.4
20:1 (ω-9) eicosenoic acid 0.9 0
Others (8:0, 17:0, 18:2, 20:0) 0.3 1.4
Unidentified fatty acids 0 1.8
Saturated fatty acids 4.5 61.7
Monounsaturated fatty acids 60.6 33.7
Polyunsaturated fatty acids 35.0 2.9
The following fatty acids analyzed did not exist in CPTRO nor in butter: 16:0(i),
16:1, 17:1, 18:3 (ω-6), 18:4 (ω-3), 18:4 (ω-3), 19:1, 20:2 (ω-6), 20:3, 20:3 (ω-3),
20:4 (ω-6), 20:5 (ω-3), 22:0, 22:1 (ω-9), 22:2, 22:3, 22:4 (ω-6), 22:5 (ω-3), 22:6 (ω-
3), 24:0, and 24:1 (ω-9).
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monoclonal anti-apoB was added. After a 60-minute
incubation at room temperature, samples were washed
again and the bound conjugate was detected by reaction
with 200 μl3 , 3 ’,5 , 5 ’-tetramethylbenzidine. Reaction was
stopped by 50 μl0 . 5MH 2SO4 and the colorimetric
endpoint was read spectrophotometrically at 450 nm.
Same experienced researcher at Kanta-Häme Central
Hospital performed all determinations of oxidized LDL.
Determination of Arterial Elasticity
An experienced nurse measured the elasticity of large and
small arteries after at least 10 minutes of rest in a semi-sit-
ting position. The recording was carried out in a tempera-
ture-controlled room after an overnight fast. Subjects were
asked to refrain from eating, smoking, drinking caffeinated
drinks and taking medication for 12 hours and drinking
alcohol for two days prior to measurement. Radial artery
pulse wave was recorded non-invasively with an arterial
tonometry (HDI/PulseWave™CR-2000) that uses a modi-
fied Windkessel pulse-contour method [11]. The capaci-
tive elasticity of large arteries (C1) and the reflective
elasticity of small arteries (C2) were automatically assessed
as a mean of five most similar pulse waves appearing dur-
ing thirty seconds of measurement. Four measurements
were performed to gain mean large and small arterial elas-
ticity for every subject. Studies were performed at the end
of both diet periods.
Statistical Analysis
Statistical analysis was carried out with the SPSS software
(version 17.0, SPSS 2009). Basic results are reported as
mean ± SD. Paired samples’ T-test was used to compare
the outcome measurements after diets in case of normal-
ity. Wilcoxon’s test was used in case of non-normality.
These results are reported as mean ± SEM. Statistical sig-
nificance was accepted at p value < 0.05.
Results
Six men withdrew because they were unable to comply
with the dietary regimens. Results include thirty-seven
subjects who completed both study periods. Baseline
characteristics of these 37 men are shown in Table 2.
There were six current smokers, twenty-one ex-smo-
kers and nine non-smokers. Twenty-one men had ear-
lier been diagnosed with hypertension, nineteen with
type 2 diabetes and six with coronary heart disease.
Pharmacological therapy consisted of aspirin or other
antiplatelet agent in fourteen, beta-blockers in sixteen,
and ACE inhibitors or angiotensin1 receptor inhibitors
in fourteen subjects, but only four were on glucose-
lowering drugs. Fifteen men were on statin medication,
two of these on combination therapy of statin and
fibrate.
Physical activity, medication and every-day diet of
participants, evaluated by a structured questionnaire,
remained stable during the study. As presented in
Figure 2, the level of oxidized LDL was significantly
lower (16%) after the cold-pressed turnip rapeseed oil
period compared to the butter period (p = 0.024).
Total and LDL cholesterol were also significantly lower
after the CPTRO period compared to the levels after
the butter period, 8% (p < 0.001) and 11% (p < 0.001),
Table 2 Basic clinical and laboratory characteristics of 37
men with metabolic syndrome accomplishing all clinical
phases of the study
Mean (SD) Range
Height, cm 177.1 (5.7) 163.0 - 191.0
Weight, kg 97.4 (16.3) 68.0 - 142.0
Waist circumference, cm 111.1 (13.1) 92.0 - 150.0
BMI, kg/m
2 31.0 (5.0) 23.9 - 46.4
SBP, mmHg 145.5 (12.3) 122.0 - 172.0
DBP, mmHg 90.8 (5.6) 80.0 - 105.0
Fasting glucose, mmol/L 6.62 (1.19) 3.3 - 9.5
HbA1C
(%) 6.42 (0.66) 5.3 - 8.7
(mmol/mol) 46.7 (7.2) 34.4 - 71.6
Total cholesterol, mmol/L 5.15 (1.49) 2.6 - 8.4
HDL-C, mmol/L 1.15 (0.27) 0.5 - 1.7
LDL-C, mmol/L 3.33 (1.25) 1.1 - 6.0
Triglycerides, mmol/L 2.19 (1.13) 0.9 - 6.3
ALAT, U/L 53.0 (27.4) 25.0 - 163.0
GT, U/L 72.4 (62.9) 15.0 - 275.0
Afos, U/L 67.6 (19.7) 30.0 - 115.0
Fibrinogen, g/L 3.49 (0.96) 2.3 - 5.5
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Figure 2 Plasma concentration of oxidized LDL at the end of
fat supplementation periods. OxLDL was 87.7 ± 5.6 U/L after the
butter and 74.2 ± 5.6 U/L after the CPTRO (cold-pressed turnip
rapeseed oil) period (p = 0.024).
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HDL cholesterol, triglycerides, glucose or HbA1C were
found between the periods. The concentration of HDL
cholesterol was 1.15 ± 0.04 mmol/L after both diet
periods. Triglycerides were 2.72 ± 0.30 mmol/L after
the butter and 2.56 ± 0.38 mmol/L after the CPTRO
periods (NS).
There were no significant differences in the mean large
or small arterial elasticity between the diet periods (Table
3). Systolic blood pressure was 138.5 ± 2.2 mmHg after the
butter and 138.5 ± 2.6 mmHg after the CPTRO period.
Diastolic blood pressures were 81.8 ± 1.4 mmHg and 81.3
± 1.6 mmHg, respectively. Weight remained stable through
the study, 97.1 ± 2.8 after the butter and 97.1 ± 2.7 after
the oil period. Total blood count showed no significant dif-
ferences between rapeseed oil and butter consumption
except in the mean corpuscular haemoglobin (31.1 ± 0.2
pg vs. 30.8 ± 0.2 pg, p = 0.01) and in the platelet count
(221.6 ± 9.0 E9/L vs. 235.4 ± 9.5 E9/L, p = 0.003).
Discussion
In this study among men with MetS dietary cold-
pressed turnip rapeseed oil was associated with favour-
able changes in lipid parameters compared to the use of
butter. The lower level of total cholesterol after CPTRO
consumption was due to the lower level of LDL choles-
terol. However, the concentration of circulating oxLDL
was proportionally even lower than that of LDL choles-
terol after the CPTRO period.
To our knowledge, this is the first report on the bene-
ficial effect of rapeseed oil on circulating oxLDL levels.
The significant reductions in total and LDL cholesterol
levels are in accordance with earlier rapeseed oil studies
[23,24]. In agreement with most of the previous studies
[23,25,26] the use of rapeseed oil did not have signifi-
cant effect on HDL cholesterol levels, although a slight
increase in HDL cholesterol by rapeseed oil has also
been reported [24].
LDL particles enriched with MUFA seem to be resis-
tant against oxidation [15-17]. Since MUFA are the main
fatty acids in rapeseed oil, this protective effect may con-
tribute to the decreased level of oxLDL after CPTRO
enriched diet in the present study. Previously, a diet with
high content of MUFA has been shown to decrease
oxLDL levels among healthy non-obese men as well as
among subjects at high cardiovascular risk [27,28].
Although effects of turnip rapeseed oil among metabolic
syndrome patients have not been studied earlier, high
MUFA-rich diet has been reported to improve oxidative
stress parameters in patients with MetS [29]. Also in a
s t u d yb yP e r o n ae ta l[ 3 0 ] ,M U F A - r i c hv i r g i no l i v eo i l
protected LDL against oxidation among type 2 diabetics.
The origin of circulating oxLDL is unknown. Oxida-
tive modification of LDL can generate minimally or fully
oxidized LDL [31]. It is generally thought that oxidation
of LDL occurs mainly in the arterial wall and only mini-
mally oxidized LDL exists in the circulation [6,31].
However, increased circulating oxLDL, determined by a
method using the same monoclonal antibody as in the
present study, is known to associate both with subclini-
cal and clinical atherosclerosis as well as to predict
future cardiovascular events [8,9,32]. Thus, dietary
manipulations that protect LDL against oxidation may
delay development of atherosclerotic lesions in patients
with MetS.
Increased glucose levels, often present among subjects
with MetS, may enhance the oxidation of lipoprotein(a)
[33]. Previously, a low-carbohydrate (LC) diet had more
favourable effects on MetS features compared to a low-
fat diet [34]. A low-carbohydrate diet has also been
reported to prevent the accumulation of oxLDL in the
arterial wall [35]. Whether a LC-diet supplemented with
CPTRO would cause even greater reductions in oxLDL
and prevent future cardiovascular events among MetS
subjects would be interesting to study.
Most dietary approaches to prevent hyperlipidaemia
and atherosclerosis have focused on the alteration of fat
m
m
o
l
/
L
Cholesterol LDL cholesterol
After butter
After CPTRO
p < 0.001
p < 0.001
Figure 3 Concentrations of total and LDL cholesterol.T o t a l
cholesterol was 5.43 ± 0.23 mmol/L at the end of the butter and
4.98 ± 0.23 mmol/L at the end of the CPTRO (cold-pressed turnip
rapeseed oil) period (p < 0.001). LDL cholesterol was 3.35 ± 0.21
mmol/L and 3.00 ± 0.18 mmol/L, respectively (p < 0.001).
Table 3 Large (C1) and small (C2) arterial elasticity at the
end of butter and oil periods
Butter period Oil period p value
C1, mL/mmHg × 10 15.5 ± 0.46 15.9 ± 0.71 NS
C2, mL/mmHg × 100 6.26 ± 0.48 6.34 ± 0.44 NS
Data are presented as mean ± SEM
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CPTRO had a cholesterol-lowering effect as a supple-
ment to the habitual diet. Turnip rapeseed oil is the
main Finnish source of unsaturated fatty acids, mainly
monounsaturated ones. By improved cultivation, MUFA
in rapeseed oil consist of an important amount of oleic
acid. Mediterranean type diet, also rich in MUFA, has
been shown to decrease total cardiovascular mortality
[13]. Compared to olive oil, common in the Mediterra-
nean region, Virgino
R rapeseed oil contains less MUFA
and SFA but a considerable amount of n-3 PUFA,
namely alfa-linolenic acid (see Table 1).
Low dose of n-3 PUFA supplement reduced early
mortality after myocardial infarction in the GISSI-
Prevenzione trial [36]. On the other hand LDL suscept-
ibility to oxidation has been assumed to associate with an
increased amount of PUFA in the small and dense LDL
particles [37]. In addition, PUFA-rich diet increased sus-
ceptibility of LDL to oxidation when compared to
MUFA-rich diet among subjects with impaired glucose
intolerance [38]. However, moderate amounts of highly
unsaturated n-3 fatty acids in a diet supplemented with
rapeseed oil did not increase LDL oxidizability when pro-
vided in the context of a diet rich in MUFA [15].
In addition to MUFA, phenolic compounds of olive oil
have been shown to reduce oxidative damage [39].
Rapeseed oil, supplemented in the present study, con-
tained only slight amounts of phenolic compounds.
Therefore, the antioxidative effect of rapeseed oil is pre-
sumably mediated mainly by the high contents of
MUFA and n-3-PUFA.
In our study, arterial elasticity seemed to be minimally
better after the CPTRO than after the butter period, but
the difference was not statistically significant. One
explanation might be that the intervention period was
too short to affect the function of the arterial wall. How-
ever, McVeigh et al [40] have found improved arterial
compliance already after a 6-week fish oil administration
in patients with non-insulin-dependent diabetes. Arterial
stiffness is not merely affected by endothelial dysfunc-
tion. For example, untreated long-lasting hypertension
and aging may cause increase in the amount of collagen
and decrease in the amount of elastin fibers in the arter-
ial wall [12]. Alterations in the elastic properties of the
arterial wall contribute to the impairment of elasticity.
Since endothelial dysfunction is a key mechanism in
atherosclerosis, a measurement of mere endothelial
function might be more sensitive in a short-term inter-
vention study [11]. Previously, a walnut diet rich in anti-
oxidants and alfa-linolenic acid for four weeks showed
an improvement in endothelial function of hypercholes-
terolaemic subjects [41]. Even one meal supplemented
with walnuts rich in n-3-PUFA, has been reported to
improve flow-mediated dilation of arteries as a sign of
improved endothelial function [42]. The same effect was
however not seen after a meal supplemented with
MUFA-rich olive oil [42]. Differences in fat type and
study groups or methods used to evaluate arterial func-
tion might explain the seeming discrepancy of the
results between the abovementioned studies and the
present one. It would be interesting to study the effects
of rapeseed oil among subjects with evidently decreased
arterial elasticity.
The platelet count was lower after the CPTRO period
in our study. It has been revealed earlier that fish oils
decrease fibrinogen level and platelet count [43]. Vegeta-
ble n-3 PUFA, like alfa-linolenic acid, is an important
constituent of the Virgino
R CPTRO. During fat metabo-
l i s mi tc a nb ec o n v e r t e dt ol o n g e rc h a i nf a t t ya c i d s
found also in fish oils. Hence, the significant decrease in
platelet count after CPTRO consumption may be attrib-
uted to the n-3 PUFA.
Strength of this study, unlike of many other dietary stu-
dies, was the balanced crossover design used to diminish
the variability between the subjects. We did not measure
the fat and energy intake by dietary records, which was a
limitation of the study. However, we ensured the stability
of both habitual diet and physical activity during the
study periods by analyzing the detailed questionnaire that
subjects filled in at the end of the intervention periods.
Previously a similar food frequency questionnaire has
been reported to be a suitable tool for ranking energy
and nutrient intake [44]. In addition, there was no differ-
ence in weight between the two dietary periods which is
in agreement with previous studies on n-3-PUFA and
MUFA rich diets [45,46]. Hence, the difference in energy
balance did not explain our findings.
A healthy cohort would have been an interesting addi-
tion to the study. However, we have previously reported
increased oxLDL levels as well as impaired large arterial
elasticity among MetS subjects compared to their
healthy, age-matched counterparts [19]. Therefore, in
the present study we wanted to focus on MetS subjects
because of their increased risk for atherosclerotic cardio-
vascular diseases.
Vegetable oils are often consumed in cooking and fry-
ing. However, repeated heating may destroy the beneficial
compounds of the oils and generate unhealthy effects
instead [47,48]. Therefore, study subjects were asked to
drink CPTRO as such, without heating or frying. Heating
or frying of fat included in the subjects’ every-day diet
was not forbidden. We cannot determine the optimal
daily dose of CPTRO based on the results of this study,
in which a constant dose of CPTRO and a comparable
amount of butter were used. Previously whipped cream
with a similar dose of SFA as used in the present study
did not cause a significant increase in postprandial oxida-
tive stress [49]. Thus, at least the dose of CPTRO, used
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ment to a diet. In practise, it may be used as such for
example in salad and dip sauces. It is worth to notice that
the study included only men with MetS. Hence, the
results cannot necessarily be generalized to the whole
population including women and men without MetS.
Conclusion
A short-time modification of the diet with cold-pressed
turnip rapeseed oil compared to butter decreased the
concentration of circulating LDL cholesterol and oxi-
dized LDL. In men with metabolic syndrome, modifica-
tion of the diet with cold-pressed turnip rapeseed oil
may be beneficial in treating hyperlipidaemia and dimin-
ishing oxidative stress and thereby delaying the progres-
sion of atherosclerosis.
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